The India Anti-Obesity Drug Market is estimated to be valued at USD 1.24 Bn in 2026 and is expected to reach USD 4.38 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 19.7% from 2026 to 2032
The water volume affects concentration and injection volume, not pharmacokinetics
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet
To view or add a comment, sign in A new article published with Psychiatric Research and Clinical Practice showed distinct risk profiles for stimulant and atomoxetine therapies during pregnancy, underscoring the need for personalized treatment decisions
Copper Peptides Mechanism: Copper peptides promote scalp health by stimulating angiogenesis (formation of new blood vessels), activating hair follicle cells, and potentially reducing DHT levels, which are linked to hair thinning
Weight loss is only the beginning
